ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
53 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
2.6K
|
863K
|
53
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
10 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
2.6K
|
863K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
12 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
2.6K
|
863K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
19 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
2.6K
|
863K
|
19
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Fifth Confirmed Response in ACCENT Trial
|
|
Mason14
|
50 |
17K |
10 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
50
|
17K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
38 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
307
|
98K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Intellectual Property (IP) Waterproofing.
|
|
Mason14
|
88 |
30K |
55 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
88
|
30K
|
55
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Fifth Confirmed Response in ACCENT Trial
|
|
Mason14
|
50 |
17K |
12 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
50
|
17K
|
12
|
|
ASX - By Stock
|
TYP |
TYP - Research, Results, Valuations, and Comparisons
|
|
Mason14
|
27 |
17K |
39 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
27
|
17K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Intellectual Property (IP) Waterproofing.
|
|
Mason14
|
88 |
30K |
33 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
88
|
30K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Intellectual Property (IP) Waterproofing.
|
|
Mason14
|
88 |
30K |
89 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
88
|
30K
|
89
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
11 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
307
|
98K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
48 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
307
|
98K
|
48
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Mason14
|
16K |
7.7M |
5 |
18/08/24 |
18/08/24 |
ASX - By Stock
|
16K
|
7.7M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
23K |
8.1M |
54 |
18/08/24 |
18/08/24 |
ASX - By Stock
|
23K
|
8.1M
|
54
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
19 |
17/08/24 |
17/08/24 |
ASX - By Stock
|
307
|
98K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
105 |
17/08/24 |
17/08/24 |
ASX - By Stock
|
307
|
98K
|
105
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
117 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
307
|
98K
|
117
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
42 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
2.6K
|
863K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
63 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
63
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
63 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
307
|
98K
|
63
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
57 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
307
|
98K
|
57
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
25 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
307
|
98K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
203 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
307
|
98K
|
203
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
1 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
307
|
98K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
288K |
67 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
924
|
288K
|
67
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
288K |
49 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
924
|
288K
|
49
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
288K |
72 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
924
|
288K
|
72
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
24K |
60 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
81
|
24K
|
60
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
24K |
17 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
81
|
24K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
24K |
51 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
24K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
24K |
38 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
24K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
24K |
15 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
24K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
24K |
65 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
24K
|
65
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Mason14
|
132 |
34K |
23 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
34K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
24K |
31 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
81
|
24K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
24K |
60 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
81
|
24K
|
60
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
31 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
2.6K
|
863K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
35 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
2.6K
|
863K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
14 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
2.6K
|
863K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
3.0K |
1.0M |
33 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
3.0K
|
1.0M
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.6K |
863K |
11 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
2.6K
|
863K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
24 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
307
|
98K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
38 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
307
|
98K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
98K |
106 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
307
|
98K
|
106
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
288K |
28 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
924
|
288K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
288K |
21 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
924
|
288K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
288K |
13 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
924
|
288K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
288K |
13 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
924
|
288K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
288K |
21 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
924
|
288K
|
21
|
|